Ann: Cogstate finalises sale of Axon Sports training business, page-5

PS... that is also why I like CGS.

I just yabbered on for 5 minutes.... just about clinical trials - being a really real revenues / cash generating machine.

--------------

For 22 cents per share (12,000,000 free-float of 100,000,000 shares) .... you also get....

1) COGNIGRAM... blue-sky revenues?

2) FDA news.... blue sky ASX feel-good factor / catch-cry.... and genuinely opens chances to new revenues?

3) Home based testing device / app.... blue sky revenues?

4) Concussion tests.... blue-sky - already mixed in with big teams in big leagues (do ya homework!)?

5) Five years of zero effort "AXON Sports" royalties... hey... even if it is just a few bucks...

6) A seat next to some seriously cashed up investors.

7) Exposure to a well-respected mini-multinational - unique in the world - unique on ASX

---------------

Some of those 7 may come to nothing..... but all carry the weight of significant potential.

And the market pays for potential just as much (if not more) as it does for cold hard cash and assets.



I shuddup.

Am pooping all over the threads.... yet again.

Me embarrass me.

bsh